Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 06 2022 - 1:20PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2022 Commission File No. 000-30087
EMPOWER CLINICS INC. |
(Translation of registrant's name into English) |
Suite 505, 1771 Robson Street Vancouver, BC
Canada V6G 1C9
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) ☐
EXHIBIT INDEX
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
EMPOWER CLINICS INC.
Date: November 28, 2022
| |
/s/ Steven McAuley | |
Steven McAuley | |
Chairman and Chief Executive Officer | |
Empower Clinics (CE) (USOTC:EPWCF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Empower Clinics (CE) (USOTC:EPWCF)
Historical Stock Chart
From Dec 2023 to Dec 2024